title: ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
abstract: The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article.
authors.affiliation: Division of Medical Gynecologic Oncology, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy clinicalguidelines@esmo.org.
authors.forename: N
authors.initials: N
authors.lastname: Colombo
authors.affiliation: Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: C
authors.initials: C
authors.lastname: Creutzberg
authors.affiliation: Department of Gynecological Oncology, University Hospital Leuven, Leuven, Belgium Center for Gynecological Oncology Amsterdam (CGOA), Antoni van Leeuwenhoek, Amsterdam.
authors.forename: F
authors.initials: F
authors.lastname: Amant
authors.affiliation: Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: T
authors.initials: T
authors.lastname: Bosse
authors.affiliation: Department of Medical Oncology, GEICO Cancer Center, Madrid Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: González-Martín
authors.affiliation: Department of Oncology and Cancer Trials, UCL Cancer Institute, London, UK.
authors.forename: J
authors.initials: J
authors.lastname: Ledermann
authors.affiliation: Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria.
authors.forename: C
authors.initials: C
authors.lastname: Marth
authors.affiliation: Department of Radiotherapy, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: R
authors.initials: R
authors.lastname: Nout
authors.affiliation: Department of Surgery, Institut Bergonié, Bordeaux, France Department of Gynecology and Obstetrics, McGill University Health Centre, Montreal, Canada.
authors.forename: D
authors.initials: D
authors.lastname: Querleu
authors.affiliation: Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
authors.forename: M R
authors.initials: MR
authors.lastname: Mirza
authors.affiliation: Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
authors.forename: C
authors.initials: C
authors.lastname: Sessa
mesh_terms: D003131:Combined Modality Therapy; D055088:Early Detection of Cancer; D016889:Endometrial Neoplasms / Q000175:diagnosis* / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008403:Mass Screening; D017410:Practice Guidelines as Topic
keywords: adjuvant; consensus; endometrial neoplasms; practice guideline; surgery; treatment